Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 10/24/2024 | $120.00 → $125.00 | Underweight | Wells Fargo | |
| 10/24/2024 | $236.00 → $238.00 | Hold | Truist | |
| 10/24/2024 | $165.00 → $195.00 | Hold | Jefferies | |
| 10/24/2024 | $245.00 → $255.00 | Neutral | Cantor Fitzgerald | |
| 10/24/2024 | $230.00 → $250.00 | Neutral | Goldman | |
| 10/24/2024 | $236.00 → $249.00 | Outperform | RBC Capital Mkts | |
| 10/24/2024 | $254.00 → $278.00 | Buy | Canaccord Genuity | |
| 10/23/2024 | $290.00 → $285.00 | Buy → Neutral | Guggenheim |
Wells Fargo reiterated coverage of Tesla with a rating of Underweight and set a new price target of $125.00 from $120.00 previously
Truist reiterated coverage of Tesla with a rating of Hold and set a new price target of $238.00 from $236.00 previously
Jefferies reiterated coverage of Tesla with a rating of Hold and set a new price target of $195.00 from $165.00 previously
4 - IGM Biosciences, Inc. (0001496323) (Issuer)
4 - IGM Biosciences, Inc. (0001496323) (Issuer)
4 - MARA Holdings, Inc. (0001507605) (Issuer)
4 - MARA Holdings, Inc. (0001507605) (Issuer)
4 - MARA Holdings, Inc. (0001507605) (Issuer)
SC 13G/A - MARA Holdings, Inc. (0001507605) (Subject)
SC 13G/A - IGM Biosciences, Inc. (0001496323) (Subject)
SC 13G/A - MARATHON DIGITAL HOLDINGS, INC. (0001507605) (Subject)
ROCKVILLE, Md., Nov. 6, 2024 /PRNewswire/ -- I-Mab (NASDAQ:IMAB) (the "Company"), a U.S.-based, global biotech company exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced that Sean (Xi-Yong) Fu, PhD, MBA has been appointed as the Company's permanent Chief Executive Officer ("CEO") effective November 1, 2024. Dr. Fu has served as Interim CEO since July 15, 2024. Dr. Fu will continue to serve as a member of the Board of Directors of I-Mab. "Sean's appointment serves as a significant step towards further rea
Fort Lauderdale, FL, Sept. 05, 2024 (GLOBE NEWSWIRE) -- MARA Holdings Inc. (NASDAQ:MARA) ("MARA" or the "Company"), a global leader in leveraging digital asset compute to support the energy transformation, today announced the appointment of Janet George and Barbara Humpton to its board of directors, and announced the appointment of current board member Doug Mellinger as lead independent director, effective September 1, 2024. Ms. George and Ms. Humpton replace Kevin DeNuccio and Said Ouissal, who have stepped down from the board, effective September 1, 2024, as part of a planned transition. Ms. George and Ms. Humpton were selected to join MARA's board for their exceptional leadership and
Engagement is part of I-Mab's commitment to transition to a U.S.-based biotech PwC to serve as independent registered public accounting firm for FY 2024 ROCKVILLE, Md., Aug. 7, 2024 /PRNewswire/ -- I-Mab (NASDAQ:IMAB) ("I-Mab", the "Company"), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced that the Audit Committee of its Board of Directors has approved the appointment of PricewaterhouseCoopers LLP (U.S.) ("PwC US") as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024, effective immediately.
HOUSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Occidental (NYSE:OXY) announced today that its Board of Directors declared a regular quarterly dividend of $0.22 per share on common stock, payable on January 15, 2025, to stockholders of record as of the close of business on December 10, 2024. About Occidental Occidental is an international energy company with assets primarily in the United States, the Middle East and North Africa. We are one of the largest oil and gas producers in the U.S., including a leading producer in the Permian and DJ basins, and offshore Gulf of Mexico. Our midstream and marketing segment provides flow assurance and maximizes the value of our oil and gas. Our c
ROCKVILLE, Md., Nov. 6, 2024 /PRNewswire/ -- I-Mab (NASDAQ:IMAB) (the "Company"), a U.S.-based, global biotech company exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced that Sean (Xi-Yong) Fu, PhD, MBA has been appointed as the Company's permanent Chief Executive Officer ("CEO") effective November 1, 2024. Dr. Fu has served as Interim CEO since July 15, 2024. Dr. Fu will continue to serve as a member of the Board of Directors of I-Mab. "Sean's appointment serves as a significant step towards further rea
Earnings Webcast and Conference Call Set for Tuesday, November 12, 2024 at 5:00 p.m. ET Fort Lauderdale, FL, Nov. 04, 2024 (GLOBE NEWSWIRE) -- MARA (NASDAQ: MARA) ("MARA" or the "Company"), a global leader in leveraging digital asset compute to support the energy transformation, will hold a webcast and conference call on Tuesday, November 12, 2024 at 5:00 p.m. Eastern time to discuss its financial results for the third quarter ended September 30, 2024. Financial results will be published in a shareholder letter prior to the call and available on the investor relations section of the Company's website. To register to participate in the conference call or to listen to the live audio we
10-Q - MCDONALDS CORP (0000063908) (Filer)
6-K - I-Mab (0001778016) (Filer)
6-K - I-Mab (0001778016) (Filer)
HOUSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Occidental (NYSE:OXY) announced today that its Board of Directors declared a regular quarterly dividend of $0.22 per share on common stock, payable on January 15, 2025, to stockholders of record as of the close of business on December 10, 2024. About Occidental Occidental is an international energy company with assets primarily in the United States, the Middle East and North Africa. We are one of the largest oil and gas producers in the U.S., including a leading producer in the Permian and DJ basins, and offshore Gulf of Mexico. Our midstream and marketing segment provides flow assurance and maximizes the value of our oil and gas. Our c
Earnings Webcast and Conference Call Set for Tuesday, November 12, 2024 at 5:00 p.m. ET Fort Lauderdale, FL, Nov. 04, 2024 (GLOBE NEWSWIRE) -- MARA (NASDAQ: MARA) ("MARA" or the "Company"), a global leader in leveraging digital asset compute to support the energy transformation, will hold a webcast and conference call on Tuesday, November 12, 2024 at 5:00 p.m. Eastern time to discuss its financial results for the third quarter ended September 30, 2024. Financial results will be published in a shareholder letter prior to the call and available on the investor relations section of the Company's website. To register to participate in the conference call or to listen to the live audio we
ROCKVILLE, Md., Oct. 31, 2024 /PRNewswire/ -- I-Mab (NASDAQ:IMAB) (the "Company"), a US-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced that it plans to release financial results for the third quarter ended September 30, 2024, on Thursday, November 14, 2024, pre-market Eastern Time. The Company will not host a conference call to discuss its third quarter 2024 financial results. The Company intends to host an investor update call in conjunction with its 2024 full-year fin
To gain an edge, this is what you need to know today. GDP Brings Buying Please click here for an enlarged chart of Invesco QQQ Trust Series 1 (NASDAQ:QQQ). Note the following: The chart shows a drop in QQQ. The drop in QQQ was triggered by speculative sentiment pulling back. As a reader of The Arora Report, you knew in advance that speculative sentiment could fall as a result of Tesla Inc (NASDAQ:TSLA) earnings. The chart shows that QQQ is approaching the support zone. RSI on the chart shows that QQQ is now oversold. Oversold markets tend to bounce. The chart shows that the volume was low on the selloff. This indicates a lack of conviction in selling. Especially hard hit in
Honda Motor Co. (NYSE:HMC) will reduce its production of gasoline vehicles in China by 19% starting this October, marking a strategic shift toward electric vehicles. The Japanese automaker will cease operations of one production line at its joint venture Dongfeng Honda, which has an annual capacity of 240,000 units, beginning in November. Additionally, in October, GAC Honda, another of its facilities with a capacity of 50,000 units annually, will be completely shut down. These changes are part of Honda's effort to accelerate the “steady shift” to EVs, reported Bloomberg. Honda’s production capacity in China, currently around 1.5 million units, will see a reduction of 19% due to
https://x.com/elonmusk/status/1816478001884004816https://x.com/elonmusk/status/1815907844434112999